SCHEMBL3342702

SCHEMBL3342702

Cc1ccc(-c2ccncc2)cc1C(N)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 5/20 0.68
SIRT3 Q9NTG7 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
PKMYT1 Q99640 2/20 0.56
CDC7 O00311 5/20 0.54
CDK9 P50750 1/20 0.52
IKBKB O14920 5/20 0.51
MKNK2 Q9HBH9 2/20 0.51
MKNK1 Q9BUB5 1/20 0.51
CSF1R P07333 4/20 0.51
IKBKE Q14164 2/20 0.50
ROCK2 O75116 2/20 0.49
MAP4K4 O95819 2/20 0.49
GSK3B P49841 2/20 0.49
CLK4 Q9HAZ1 2/20 0.49
BTK Q06187 1/20 0.48
CCNC P24863 1/20 0.47
CDK8 P49336 1/20 0.47
DYRK3 O43781 1/20 0.47
RPS6KA5 O75582 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28163150 0.86 MKNK2 (0.68) CHUKSIRT3TDP1PKMYT1CDC7
SCHEMBL3346124 0.83 PIK3CB (0.67) CHUKSIRT3TDP1PKMYT1MKNK2
SCHEMBL7120106 0.82 IKBKB (0.66) CHUKPKMYT1IKBKBMKNK2MKNK1
SCHEMBL3343643 0.81 MKNK1 (0.54) CHUKSIRT3TDP1PKMYT1IKBKB
SCHEMBL3226601 0.81 MKNK1 (0.78) SIRT3TDP1MKNK2MKNK1BTK
SCHEMBL5302307 0.81 CHUK (1.00) CHUKPKMYT1CDC7CDK9IKBKB
SCHEMBL5306999 0.81 CHUK (0.70) CHUKPKMYT1CDC7CDK9IKBKB
SCHEMBL3382180 0.79 CHUK (0.68) CHUKPKMYT1CDC7CDK9IKBKB
SCHEMBL3386608 0.79 CHUK (0.68) CHUKPKMYT1CDC7CDK9IKBKB
SCHEMBL3342287 0.78 MKNK2 (0.47) CHUKSIRT3TDP1IKBKBMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 CHUK 1510/4885SIRT3 315/4885TDP1 1578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.